⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL270953 | 0.77 | — | — | |
| SCHEMBL16532503 | 0.76 | USP2 (0.33) | — | |
| SCHEMBL9814035 | 0.74 | TSHR (0.47) | — | |
| SCHEMBL270440 | 0.73 | USP2 (0.33) | — | |
| SCHEMBL9825921 | 0.72 | USP2 (0.33) | — | |
| SCHEMBL209008 | 0.70 | — | — | |
| SCHEMBL10876817 | 0.69 | CA12 (0.37) | — | |
| SCHEMBL196234 | 0.69 | — | — | |
| SCHEMBL22053841 | 0.69 | USP2 (0.42) | — | |
| SCHEMBL23894276 | 0.69 | USP2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1263324-B1 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | VERITAS PHARMACEUTICALS (US) | 2009-12-02 | — | — | EP | disclosed |
| US-20040170561-A1 | Functional radiographic imaging methods and agents | SALB JESSE (US) | 2004-09-02 | — | — | US | disclosed |
| US-6751290-B2 | Radiographic assessment of tissue after exposure to a compound | VERITAS PHARMACEUTICALS, INC. | 2004-06-15 | — | — | US | disclosed |
| US-6723746-B2 | CELL MEMBRANE-PERMEABLE, RADIO-OPAQUE IMAGING AGENT | VERITAS PHARMACEUTICALS, INC. | 2004-04-20 | — | — | US | disclosed |
| EP-1263478-A2 | FUNCTIONAL RADIOGRAPHIC IMAGING METHODS AND AGENTS | Veritas Pharmaceuticals (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1263323-A2 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | Veritas Pharmaceuticals (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1263324-A2 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | Veritas Pharmaceuticals (US) | 2002-12-11 | — | — | EP | disclosed |
| US-20020039401-A1 | Radiographic assessment of tissue after exposure to a compound | VERITAS PHARMACEUTICALS, INC. | 2002-04-04 | — | — | US | disclosed |
| US-20010038682-A1 | Radiographic assessment of tissue response to compounds | VERITAS PHARMACEUTICALS INC., A DELAWARE CORP. | 2001-11-08 | — | — | US | disclosed |
| US-20010031035-A1 | Functional radiographic imaging methods and agents | VERITAS PHARMACEUTICALS INC. | 2001-10-18 | — | — | US | disclosed |
| WO-2001068151-A2 | FUNCTIONAL RADIOGRAPHIC IMAGING METHODS AND AGENTS | VERITAS PHARMACEUTICALS (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001067958-A2 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | VERITAS PHARMACEUTICALS (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001067959-A2 | RADIOGRAPHIC ASSESSMENT OF TISSUE RESPONSE TO COMPOUNDS | VERITAS PHARMACEUTICALS (US) | 2001-09-20 | — | — | WO | disclosed |